Skip to content
DraconiticResearch
Search Sources API
201,683 studies31 sourcesUpdated 24 min ago
Peer-reviewedCC BY-NC-NDJournal of the American Heart Association

Global Prevalence of Adherence to Antihypertensives and Associated Moderating Factors Among Adults With Hypertension: A Meta‐Analysis

8 affiliations
  1. 1National Taipei University of Nursing and Health Sciences
  2. 2Mzimba District Hospital
  3. 3St John's Institute for Health
  4. 4Taipei Medical University
  5. 5Kamuzu University of Health Sciences
  6. 6University of Wisconsin–Milwaukee
  7. 7Mzuzu Central Hospital
  8. 8Independent Researcher

Abstract

BACKGROUND: Hypertension is a significant public health issue affecting over a billion adults worldwide with adherence to antihypertensives being crucial for achieving sustained blood pressure control and reducing cardiovascular morbidity and mortality. To extend previous evidence, we conducted a meta-analysis on global prevalence of adherence to antihypertensives among adults. METHODS: statistics examined statistical heterogeneity with moderator analysis exploring sources of heterogeneity. Sensitivity analysis was analyzed using exact fixed-effects model. RESULTS: A total of 123 studies with 1 052 445 adults with hypertension were included. Pooled global prevalence of adherence to antihypertensives was estimated at 58% (95% CI, 52%-63%), with 39% for high adherence, 29% for moderate adherence, and 35% for low adherence. Results for sensitivity analysis were 57.91% (95% CI, 57.81%-58.01%) with δ̂ being 24.3%. Prevalence across continents was 67% for Europe, 65% for South America, 60% for Africa, 56% for Asia, and 45% for North America. Adherence to antihypertensives was similar across low-income countries (61%), high-income countries (58), upper-middle-income countries (57%), and lower-middle-income countries (56%). In multivariate model, age and assessment tool only were significantly associated with medication adherence. CONCLUSIONS: Globally, a large proportion of adults with hypertension exhibit moderate to low adherence to antihypertensive medications. Future studies should prioritize establishing consensus-based operational definitions and cutoff values to enhance adherence.

Related

  1. Prevalence and Associated Factors of Hypertension–Diabetes–Dyslipidemia Clustering Among Adults — Hainan Province, China, 2023
    Juan Jiang, Tingting Ou, Ying Liu +6
    China CDC weeklyPeer-reviewedCC BY-NCFull textGeneral medicineEurope PMC
  2. Prevalence and factors associated with pulmonary hypertension in patients undergoing maintenance hemodialysis: a systematic review and meta-analysis
    Hong-wei Yang, Juan Wang, Hui Ji +6
    Frontiers in medicinePeer-reviewedCC BYFull textGeneral medicineEurope PMC
  3. Prevalence of hypertension and associated factors among slum residents in Mbarara City, Uganda, 2024
    Richard Migisha, Charity Mutesi, Derrick Asiimwe +6
    Journal of Interventional Epidemiology and Public HealthPeer-reviewedCC BYFull textCardiovascular medicineDOAJ
  4. Age-stratified prevalence and associated risk factors of hypertension, diabetes and hypercholesterolemia in Nepal: Insights from the STEPS survey 2019
    Durga Datta Chapagain, Kennedy Mensah Osei, Iga Danik Prasiska +6
    PLOS OnePeer-reviewedCC BY 4.0Full textCardiovascular medicineEndocrinology & metabolismPLOS
  5. Prevalence and factors associated with pre-exposure prophylaxis adherence among HIV-negative partners in serodifferent relationships attending selected health facilities in Gulu District, Uganda
    Aromorach Vivian Calo, Tom Ngabirano, Andrew Mujugira +2
    BMC Public HealthPeer-reviewedCC BY 4.0Infectious diseaseCrossref
BibTeX
@article{ngolombe2026global,
  title = {{Global Prevalence of Adherence to Antihypertensives and Associated Moderating Factors Among Adults With Hypertension: A Meta‐Analysis}},
  author = {Reymond Ngolombe and Burnett C. Chiona and Fikile Khangamwa Singano and Frank Sinyiza and Zizwani B. Chilinda and Tsae‐Jyy Wang},
  journal = {Journal of the American Heart Association},
  year = {2026},
  month = oct,
  doi = {10.1161/jaha.125.047824},
  url = {https://www.ahajournals.org/doi/10.1161/JAHA.125.047824},
  note = {CC BY-NC-ND},
}
RIS
TY  - JOUR
TI  - Global Prevalence of Adherence to Antihypertensives and Associated Moderating Factors Among Adults With Hypertension: A Meta‐Analysis
AU  - Reymond Ngolombe
AU  - Burnett C. Chiona
AU  - Fikile Khangamwa Singano
AU  - Frank Sinyiza
AU  - Zizwani B. Chilinda
AU  - Tsae‐Jyy Wang
PY  - 2026
DA  - 2026/10/20
JO  - Journal of the American Heart Association
DO  - 10.1161/jaha.125.047824
UR  - https://www.ahajournals.org/doi/10.1161/JAHA.125.047824
AB  - BACKGROUND: Hypertension is a significant public health issue affecting over a billion adults worldwide with adherence to antihypertensives being crucial for achieving sustained blood pressure control and reducing cardiovascular morbidity and mortality. To extend previous evidence, we conducted a meta-analysis on global prevalence of adherence to antihypertensives among adults. METHODS: statistics examined statistical heterogeneity with moderator analysis exploring sources of heterogeneity. Sensitivity analysis was analyzed using exact fixed-effects model. RESULTS: A total of 123 studies with 1 052 445 adults with hypertension were included. Pooled global prevalence of adherence to antihypertensives was estimated at 58% (95% CI, 52%-63%), with 39% for high adherence, 29% for moderate adherence, and 35% for low adherence. Results for sensitivity analysis were 57.91% (95% CI, 57.81%-58.01%) with δ̂ being 24.3%. Prevalence across continents was 67% for Europe, 65% for South America, 60% for Africa, 56% for Asia, and 45% for North America. Adherence to antihypertensives was similar across low-income countries (61%), high-income countries (58), upper-middle-income countries (57%), and lower-middle-income countries (56%). In multivariate model, age and assessment tool only were significantly associated with medication adherence. CONCLUSIONS: Globally, a large proportion of adults with hypertension exhibit moderate to low adherence to antihypertensive medications. Future studies should prioritize establishing consensus-based operational definitions and cutoff values to enhance adherence.
SN  - 2047-9980
ER  -